BIOMAT Database Logo BIOMAT Database Logo

Toxicology and carcinogenesis studies of ozone and ozone 4-(N-nitrosomethylamino)-1-(3-pyridyl)-1-butanone in Fischer-344/N rats. 1994

G A Boorman, and R Hailey, and S Grumbein, and B J Chou, and R A Herbert, and T Goehl, and P W Mellick, and J H Roycroft, and J K Haseman, and R Sills
Pathology Branch, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709.

The purpose of this study was to evaluate the toxicity and potential carcinogenicity or cocarcinogenicity of ozone exposure in rats. Fischer-344/N (F-344/N) rats were exposed 6 hr/day, 5 days/wk, to 0, 0.12, 0.5, or 1.0 ppm ozone by inhalation for 2-yr and lifetime exposures. The cocarcinogenicity study included subcutaneous administration of 0, 0.1, or 1.0 mg/kg body weight of 4-(N-nitrosomethylamino)-1-(3-pyridyl)-1-butanone (NNK) and inhalation of 0 or 0.5 ppm ozone to male rats. NNK was administered by subcutaneous injections 3 times per week for the first 20 wk with ozone inhalation exposure. The ozone inhalation exposure was for 2 yr (104 wk), including the first 20 wk of NNK treatment and continuing for 84 wk after the last NNK injection. Ozone exposure caused a concentration-related increase in inflammation of the centriacinar region of the lung. There was also increased fibrosis and an extension of the bronchiolar epithelium in these centriacinar regions to involve the proximal alveoli. There was no increased incidence of neoplasms at any site, including the lung, that was associated with ozone exposure. Rats administered 1.0 mg/kg body weight NNK alone had an increased incidence of bronchiolar/alveolar neoplasms, but this effect was not enhanced by ozone exposure. Ozone exposure for 2 yr and lifetime was associated with site-specific toxic alterations in the nasal passage and lung similar to those previously described for short-term exposures. While there was significant attenuation of the pulmonary lesions as compared to short-term exposures, lesions persisted in the lifetime study and there was evidence of a mild progressive fibrosis. We conclude that under the conditions of these studies: (a) ozone exposure is not carcinogenic to either male or female F-344/N rats, (b) ozone does not enhance the incidence of pulmonary neoplasms in F-344/N rats exposed to a known pulmonary carcinogen (NNK), and (c) mild site-specific toxic lesions characteristic of ozone exposure persist in the nasal passage and lung throughout the lifetime of the rat with continued ozone exposure.

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008297 Male Males
D009602 Nitrosamines A class of compounds that contain a -NH2 and a -NO radical. Many members of this group have carcinogenic and mutagenic properties. Nitrosamine
D010126 Ozone The unstable triatomic form of oxygen, O3. It is a powerful oxidant that is produced for various chemical and industrial uses. Its production is also catalyzed in the ATMOSPHERE by ULTRAVIOLET RAY irradiation of oxygen or other ozone precursors such as VOLATILE ORGANIC COMPOUNDS and NITROGEN OXIDES. About 90% of the ozone in the atmosphere exists in the stratosphere (STRATOSPHERIC OZONE). Ground Level Ozone,Low Level Ozone,Tropospheric Ozone,Level Ozone, Ground,Level Ozone, Low,Ozone, Ground Level,Ozone, Low Level,Ozone, Tropospheric
D011916 Rats, Inbred F344 An inbred strain of rat that is used for general BIOMEDICAL RESEARCH purposes. Fischer Rats,Rats, Inbred CDF,Rats, Inbred Fischer 344,Rats, F344,Rats, Inbred Fisher 344,CDF Rat, Inbred,CDF Rats, Inbred,F344 Rat,F344 Rat, Inbred,F344 Rats,F344 Rats, Inbred,Inbred CDF Rat,Inbred CDF Rats,Inbred F344 Rat,Inbred F344 Rats,Rat, F344,Rat, Inbred CDF,Rat, Inbred F344,Rats, Fischer
D012137 Respiratory System The tubular and cavernous organs and structures, by means of which pulmonary ventilation and gas exchange between ambient air and the blood are brought about. Respiratory Tract,Respiratory Systems,Respiratory Tracts,System, Respiratory,Tract, Respiratory
D002273 Carcinogens Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. Carcinogen,Oncogen,Oncogens,Tumor Initiator,Tumor Initiators,Tumor Promoter,Tumor Promoters,Initiator, Tumor,Initiators, Tumor,Promoter, Tumor,Promoters, Tumor
D003043 Cocarcinogenesis The combination of two or more different factors in the production of cancer. Cocarcinogeneses
D005260 Female Females
D000280 Administration, Inhalation The administration of drugs by the respiratory route. It includes insufflation into the respiratory tract. Drug Administration, Inhalation,Drug Administration, Respiratory,Drug Aerosol Therapy,Inhalation Drug Administration,Inhalation of Drugs,Respiratory Drug Administration,Aerosol Drug Therapy,Aerosol Therapy, Drug,Drug Therapy, Aerosol,Inhalation Administration,Administration, Inhalation Drug,Administration, Respiratory Drug,Therapy, Aerosol Drug,Therapy, Drug Aerosol

Related Publications

G A Boorman, and R Hailey, and S Grumbein, and B J Chou, and R A Herbert, and T Goehl, and P W Mellick, and J H Roycroft, and J K Haseman, and R Sills
4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone.
January 2004, Report on carcinogens : carcinogen profiles,
G A Boorman, and R Hailey, and S Grumbein, and B J Chou, and R A Herbert, and T Goehl, and P W Mellick, and J H Roycroft, and J K Haseman, and R Sills
4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone.
January 2002, Report on carcinogens : carcinogen profiles,
G A Boorman, and R Hailey, and S Grumbein, and B J Chou, and R A Herbert, and T Goehl, and P W Mellick, and J H Roycroft, and J K Haseman, and R Sills
N-Nitrosamines (15 listings): 4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone.
January 2011, Report on carcinogens : carcinogen profiles,
G A Boorman, and R Hailey, and S Grumbein, and B J Chou, and R A Herbert, and T Goehl, and P W Mellick, and J H Roycroft, and J K Haseman, and R Sills
Antimutagenicity of cyclohexanol towards 4-(N-nitrosomethylamino)-1-(3-pyridyl)-1-butanone and N-nitrosodiethylamine in Salmonella typhimurium strain TA100.
August 1993, Mutation research,
G A Boorman, and R Hailey, and S Grumbein, and B J Chou, and R A Herbert, and T Goehl, and P W Mellick, and J H Roycroft, and J K Haseman, and R Sills
Characterization of activation and deactivation pathways of 4-(N-nitrosomethylamino)-1-(3-pyridyl)-1-butanone (NNK) in rat hepatocytes.
January 1991, IARC scientific publications,
G A Boorman, and R Hailey, and S Grumbein, and B J Chou, and R A Herbert, and T Goehl, and P W Mellick, and J H Roycroft, and J K Haseman, and R Sills
Inhibition of tobacco-specific nitrosamine 4-(N-nitrosomethylamino)-1-(3-pyridyl)-1-butanone (NNK) tumorigenesis with aromatic isothiocyanates.
January 1991, IARC scientific publications,
G A Boorman, and R Hailey, and S Grumbein, and B J Chou, and R A Herbert, and T Goehl, and P W Mellick, and J H Roycroft, and J K Haseman, and R Sills
Antimutagenic and anticarcinogenic effects of betel leaf extract against the tobacco-specific nitrosamine 4-(N-nitrosomethylamino)-1-(3-pyridyl)-1-butanone (NNK).
January 1991, IARC scientific publications,
G A Boorman, and R Hailey, and S Grumbein, and B J Chou, and R A Herbert, and T Goehl, and P W Mellick, and J H Roycroft, and J K Haseman, and R Sills
Molecular dosimetry of O6-methylguanine formation and cell toxicity in lung and nasal mucosa by 4-(N-nitrosomethylamino)-1-(3-pyridyl)-1-butanone.
January 1987, IARC scientific publications,
G A Boorman, and R Hailey, and S Grumbein, and B J Chou, and R A Herbert, and T Goehl, and P W Mellick, and J H Roycroft, and J K Haseman, and R Sills
Mutagenic and cytogenetic studies of N'-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.
August 1989, Cancer letters,
G A Boorman, and R Hailey, and S Grumbein, and B J Chou, and R A Herbert, and T Goehl, and P W Mellick, and J H Roycroft, and J K Haseman, and R Sills
Carcinogenicity and DNA adduct formation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and enantiomers of its metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in F-344 rats.
December 2014, Carcinogenesis,
Copied contents to your clipboard!